Drugs News and Research

RSS

Princeton scientists test cell-culture system to aid study of HBV infections

Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections

25 Jul 2017

Researchers understand how to prevent severe weight loss in cancer patients

Many cancer patients are susceptible to potentially lethal weight loss. Now researchers understand better why this happens, and perhaps how to prevent the condition.

25 Jul 2017

New map may be first step to developing treatments for complex brain disorders

Just as parents are not the root of all their children's problems, a single gene mutation can't be blamed for complex brain disorders like autism, according to a Keck School of Medicine of USC neuroscientist.

25 Jul 2017

Study shows how E. coli bacteria hijack copper, use it as nutrient to fuel growth

Copper has long been known for its ability to kill bacteria and other microbes. But in an interesting twist, researchers at Washington University School of Medicine in St. Louis have shown that Escherichia coli (E. coli) bacteria - those at the root of hard-to-treat urinary tract infections (UTIs) - hijack trace amounts of copper in the body and use it as a nutrient to fuel growth.

24 Jul 2017

Transgender women cite harmful drug interactions as reason for not taking anti-HIV medications

Transgender women -- people whose birth certificates indicate or once indicated male sex but who identify as women -- are at high risk of HIV acquisition, and thus are a key population for HIV prevention and treatment efforts.

24 Jul 2017

Critical research strategies and interventions established for pediatric and adolescent HIV

The highest priority research agendas needed to improve the testing and treatment of children and adolescents with HIV were presented at the 9th International Aids Society (IAS) Conference on HIV Science in Paris this weekend.

24 Jul 2017

Diagnosing prostate cancer through a £225 urine test

This test, which we have branded SelectMDx for Prostate Cancer, came with the acquisition of a company in the Netherlands called NovioGendix. They developed a prototype assay, so they did most of the heavy lifting in terms of discovering the two specific biomarkers that are currently in the product. These biomarkers are tuned towards the detection of what I call clinically significant prostate cancer.

24 Jul 2017

Established therapeutic drugs may be effective against childhood dementia

Although dementia is most often seen in adults, childhood or adolescent dementia does occur. A team of researchers from the University of Würzburg believes that established therapeutic drugs might be effective against childhood dementia.

24 Jul 2017

Testing treatments using pig model may help minimize drug failure rates for chronic conditions

Scientists may be able to minimize the failure rate of drugs for diseases linked to high-calorie diets, such as colon cancer and type 2 diabetes, if they test treatments using a pig model, according to an international team of researchers.

21 Jul 2017

WHO alerts countries to increasing trend of HIV drug resistance

WHO alerts countries to the increasing trend of resistance to HIV drugs detailed in a report based on national surveys conducted in several countries.

21 Jul 2017

Trump plan might cut expenses for some insured patients with chronic needs

Erin Corbelli takes three medications to treat high blood pressure, depression and an anxiety disorder. Her health plan covers her drugs and specialist visits, but Corbelli and her family must pay a $3,000 annual deductible before the plan starts picking up any of that tab.

21 Jul 2017

New genomic research partnership promises to redefine and transform cancer treatment

Personalized cancer therapies are on the horizon thanks to a new genomic cancer research partnership between the Gene Editing Institute of Christiana Care Health System's Helen F. Graham Cancer Center & Research Institute and the biotechnology company NovellusDx.

21 Jul 2017

Noninvasive treatment uses cooled radio energy to provide relief from arthritis pain

Pain medicine specialists at Rush have helped develop, and are among the first in the country to provide, a noninvasive treatment for knee arthritis that uses cooled radio energy to target and interrupt pain signals.

21 Jul 2017

Researchers devise strategy to target Achilles heel of nervous system cancers

Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment.

21 Jul 2017

Merck, Pfizer and Corning join forces to modernize pharmaceutical glass packaging

Merck, Pfizer and Corning Incorporated today announced collaborations that have enabled the modernization of pharmaceutical packaging with the introduction of Corning Valor Glass.

20 Jul 2017

UAlberta researchers find strong clues to underlying cause of HIV-associated neurocognitive disorders

UAlberta researchers believe they now have a clearer picture of why people living with HIV so commonly suffer from dementia and other neurocognitive disorders.

20 Jul 2017

AIDS deaths halve and 19 million people on life saving treatment

Yesterday the UNAIDS released a report that showed for the first time a decline in the number of deaths due to AIDS. Now more than half of the individuals who have been infected with the HIV virus i.e. 53% have access to treatment with life saving medications for AIDS compared to data from 2005.

20 Jul 2017

FDA clears first MRI device for neonatal brain and head imaging

Today, the U.S. Food and Drug Administration cleared the first magnetic resonance imaging device specifically for neonatal brain and head imaging in neonatal intensive care units.

20 Jul 2017

Wastewater may become key ally in the fight against antibiotic-resistant microorganisms

Municipal wastewater may become a key ally in the fight against antibiotic-resistant disease-causing bacteria and fungi, a new study at Stellenbosch University found.

20 Jul 2017

Study: Response to combination immunotherapy in melanoma depends on proportion of immune cells

Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco researchers joined by physicians from UCSF Health.

20 Jul 2017

Drugs News and Research

Princeton scientists test cell-culture system to aid study of HBV infections

Researchers understand how to prevent severe weight loss in cancer patients

New map may be first step to developing treatments for complex brain disorders

Study shows how E. coli bacteria hijack copper, use it as nutrient to fuel growth

Transgender women cite harmful drug interactions as reason for not taking anti-HIV medications

Critical research strategies and interventions established for pediatric and adolescent HIV

Diagnosing prostate cancer through a £225 urine test

Established therapeutic drugs may be effective against childhood dementia

Testing treatments using pig model may help minimize drug failure rates for chronic conditions

WHO alerts countries to increasing trend of HIV drug resistance

Trump plan might cut expenses for some insured patients with chronic needs

New genomic research partnership promises to redefine and transform cancer treatment

Noninvasive treatment uses cooled radio energy to provide relief from arthritis pain

Researchers devise strategy to target Achilles heel of nervous system cancers

Merck, Pfizer and Corning join forces to modernize pharmaceutical glass packaging

UAlberta researchers find strong clues to underlying cause of HIV-associated neurocognitive disorders

AIDS deaths halve and 19 million people on life saving treatment

FDA clears first MRI device for neonatal brain and head imaging

Wastewater may become key ally in the fight against antibiotic-resistant microorganisms

Study: Response to combination immunotherapy in melanoma depends on proportion of immune cells

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News